[
    "{\"step_by_step_thinking\": \"Semagacestat is a gamma-secretase inhibitor that was initially developed as a potential treatment for Alzheimer's Disease. However, clinical trials of Semagacestat showed disappointing results. In fact, the Phase III clinical trial of Semagacestat was stopped early due to safety concerns and lack of efficacy. The drug was found to worsen cognitive function and increase the risk of skin cancer. Therefore, based on the available evidence, Semagacestat is not effective for Alzheimer's Disease.\", \"answer_choice\": \"B. no\"}"
]